How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
<h4>Background</h4>Onchocerciasis (river-blindness) in Africa is targeted for elimination through mass drug administration (MDA) with ivermectin. Onchocerciasis may cause various types of skin and eye disease. Predicting the impact of MDA on onchocercal morbidity is useful for future pol...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67c3e503d2574b8d9810145e9f64d819 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:67c3e503d2574b8d9810145e9f64d819 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:67c3e503d2574b8d9810145e9f64d8192021-11-25T06:33:08ZHow does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?1935-27271935-273510.1371/journal.pntd.0009489https://doaj.org/article/67c3e503d2574b8d9810145e9f64d8192021-06-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009489https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Onchocerciasis (river-blindness) in Africa is targeted for elimination through mass drug administration (MDA) with ivermectin. Onchocerciasis may cause various types of skin and eye disease. Predicting the impact of MDA on onchocercal morbidity is useful for future policy development. Here, we introduce a new disease module within the established ONCHOSIM model to predict trends over time in prevalence of onchocercal morbidity.<h4>Methods</h4>We developed novel generic model concepts for development of symptoms due to cumulative exposure to dead microfilariae, accommodating both reversible (acute) and irreversible (chronic) symptoms. The model was calibrated to reproduce pre-control age patterns and associations between prevalences of infection, eye disease, and various types of skin disease as observed in a large set of population-based studies. We then used the new disease module to predict the impact of MDA on morbidity prevalence over a 30-year time frame for various scenarios.<h4>Results</h4>ONCHOSIM reproduced observed age-patterns in disease and community-level associations between infection and disease reasonably well. For highly endemic settings with 30 years of annual MDA at 60% coverage, the model predicted a 70% to 89% reduction in prevalence of chronic morbidity. This relative decline was similar with higher MDA coverage and only somewhat higher for settings with lower pre-control endemicity. The decline in prevalence was lowest for mild depigmentation and visual impairment. The prevalence of acute clinical manifestations (severe itch, reactive skin disease) declined by 95% to 100% after 30 years of annual MDA, regardless of pre-control endemicity.<h4>Conclusion</h4>We present generic model concepts for predicting trends in acute and chronic symptoms due to history of exposure to parasitic worm infections, and apply this to onchocerciasis. Our predictions suggest that onchocercal morbidity, in particular chronic manifestations, will remain a public health concern in many epidemiological settings in Africa, even after 30 years of MDA.Natalie V S Vinkeles MelchersWilma A StolkMichele E MurdochBelén PedriqueMarielle KloekRoel BakkerSake J de VlasLuc E CoffengPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 6, p e0009489 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Natalie V S Vinkeles Melchers Wilma A Stolk Michele E Murdoch Belén Pedrique Marielle Kloek Roel Bakker Sake J de Vlas Luc E Coffeng How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? |
description |
<h4>Background</h4>Onchocerciasis (river-blindness) in Africa is targeted for elimination through mass drug administration (MDA) with ivermectin. Onchocerciasis may cause various types of skin and eye disease. Predicting the impact of MDA on onchocercal morbidity is useful for future policy development. Here, we introduce a new disease module within the established ONCHOSIM model to predict trends over time in prevalence of onchocercal morbidity.<h4>Methods</h4>We developed novel generic model concepts for development of symptoms due to cumulative exposure to dead microfilariae, accommodating both reversible (acute) and irreversible (chronic) symptoms. The model was calibrated to reproduce pre-control age patterns and associations between prevalences of infection, eye disease, and various types of skin disease as observed in a large set of population-based studies. We then used the new disease module to predict the impact of MDA on morbidity prevalence over a 30-year time frame for various scenarios.<h4>Results</h4>ONCHOSIM reproduced observed age-patterns in disease and community-level associations between infection and disease reasonably well. For highly endemic settings with 30 years of annual MDA at 60% coverage, the model predicted a 70% to 89% reduction in prevalence of chronic morbidity. This relative decline was similar with higher MDA coverage and only somewhat higher for settings with lower pre-control endemicity. The decline in prevalence was lowest for mild depigmentation and visual impairment. The prevalence of acute clinical manifestations (severe itch, reactive skin disease) declined by 95% to 100% after 30 years of annual MDA, regardless of pre-control endemicity.<h4>Conclusion</h4>We present generic model concepts for predicting trends in acute and chronic symptoms due to history of exposure to parasitic worm infections, and apply this to onchocerciasis. Our predictions suggest that onchocercal morbidity, in particular chronic manifestations, will remain a public health concern in many epidemiological settings in Africa, even after 30 years of MDA. |
format |
article |
author |
Natalie V S Vinkeles Melchers Wilma A Stolk Michele E Murdoch Belén Pedrique Marielle Kloek Roel Bakker Sake J de Vlas Luc E Coffeng |
author_facet |
Natalie V S Vinkeles Melchers Wilma A Stolk Michele E Murdoch Belén Pedrique Marielle Kloek Roel Bakker Sake J de Vlas Luc E Coffeng |
author_sort |
Natalie V S Vinkeles Melchers |
title |
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? |
title_short |
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? |
title_full |
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? |
title_fullStr |
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? |
title_full_unstemmed |
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? |
title_sort |
how does onchocerciasis-related skin and eye disease in africa depend on cumulative exposure to infection and mass treatment? |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/67c3e503d2574b8d9810145e9f64d819 |
work_keys_str_mv |
AT natalievsvinkelesmelchers howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment AT wilmaastolk howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment AT micheleemurdoch howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment AT belenpedrique howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment AT mariellekloek howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment AT roelbakker howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment AT sakejdevlas howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment AT lucecoffeng howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment |
_version_ |
1718413687691149312 |